Crossmark

ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.02.026

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Öztürk, Gökcan https://orcid.org/0000-0001-8958-7968
Bayrakoğlu, Deniz https://orcid.org/0000-0002-2972-0277
Haskoloğlu, Şule https://orcid.org/0000-0002-2668-0441
Baskın, Kübra https://orcid.org/0000-0002-4294-7492
Deveci, Nazlı https://orcid.org/0000-0002-3390-7798
İnce, Elif https://orcid.org/0000-0002-6846-6048
İleri, Talia https://orcid.org/0000-0002-0244-353X
Çakmaklı, Hasan https://orcid.org/0000-0003-0152-1564
Ertem, Mehmet https://orcid.org/0000-0002-8173-7885
İkincioğulları, Aydan https://orcid.org/0000-0003-1145-0843
Doğu, Figen https://orcid.org/0000-0002-7869-4941
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-04-09
More Information

This article is maintained by: Elsevier

Article Title: ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.02.026

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.